Earnings History Data for Novo Nordisk (NVO) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Novo Nordisk

Novo Nordisk is a world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Furthermore the company is the world's largest producer of industrial enzyme products. The company believes that everyone must care for the environment and our natural resources.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
31-01-2024	PM		NVO	Novo Nordisk	484,968	0.71	0.66	0.00	Novo Nordisk reports Q4 earnings; initiates FY24 outlook [1/31/2024 1:40 AM]	114.87	5.85 (5.37%)	112.37	3.35 (3.07%)	65.58 - 116.12	10,821,431	4,060,000	728,736
Novo Nordisk reports Q4 earnings; initiates FY24 outlook [1/31/2024 1:40 AM] Novo Nordisk FY 2023 Earnings Preview [1/30/2024 11:19 AM] Novo Nordisk stock hits all-time high as Wegovy boosts 2023 results [1/31/2024 5:29 AM] Lilly, Novo could be first trillion-dollar health stocks: world's largest sovereign wealth fund [1/31/2024 12:32 PM]
02-11-2023	PM		NVO	Novo Nordisk A/S	432,440	0.73	0.69	0.43	Novo Nordisk GAAP EPS of DKK 5.00, revenue of DKK 58.73B; raises FY23 sales guidance [11/2/2023 2:41 AM]	100.93	3.25 (3.33%)	100.93	0.0 (0.00%)	54.85 - 104.00	4,847,862	3,480,000	24,636
Novo Nordisk GAAP EPS of DKK 5.00, revenue of DKK 58.73B; raises FY23 sales guidance [11/2/2023 2:41 AM] Novo Nordisk raises outlook buoyed by strong sales of weight loss drug [11/2/2023 5:48 AM] Novo Nordisk says ~80% of insured U.S. patients pay less than $25 for Wegovy [11/2/2023 2:26 PM]
10-08-2023	PM		NVO	Novo Nordisk A/S	363,000	1.26	1.34	0.84	Novo Nordisk GAAP EPS of DKK 8.63, revenue of DKK 54.3B; raises FY23 sales guidance [8/10/2023 3:20 AM]	182.09	-5.50 (-2.93%)	184.73	-2.86 (-1.52%)	95.02 - 192.18	2,733,081	2,180,000	406,558
Novo Nordisk Q2 2023 Earnings Preview [8/9/2023 11:29 AM] Novo Nordisk GAAP EPS of DKK 8.63, revenue of DKK 54.3B; raises FY23 sales guidance [8/10/2023 3:20 AM] Novo Nordisk raises outlook as obesity franchise outperforms in Q2 [8/10/2023 7:12 AM] Novo Nordisk declares DKK 6.00 interim dividend [8/10/2023 9:21 AM] Novo Nordisk to buy Canadian weight loss drug developer Inversago [8/10/2023 12:03 PM]
04-05-2023	PM	0:00 AM ET (May 4)	NVO	Novo Nordisk	378,368	1.27	1.27	0.00	Novo Nordisk GAAP EPS of DKK8.78, revenue of DKK53.37B; updates FY23 outlook [5/4/2023 3:20 AM]	160.45	-7.32 (-4.36%)	162.06	-5.71 (-3.40%)	95.02 - 172.97	2,427,091	1,240,000	181,344
Novo Nordisk stock dips as Wegovy sales miss, drug's US supply hit amid demand [5/4/2023 5:21 AM] Novo Nordisk GAAP EPS of DKK8.78, revenue of DKK53.37B; updates FY23 outlook [5/4/2023 3:20 AM] Novo Nordisk to report Q1 2023 results with Wegovy sales in focus [5/3/2023 1:13 PM]
29-04-2022	PM		NVO	Novo Nordisk	262,702	0.94	0.85	0.00	Novo Nordisk GAAP EPS of DKK6.22, revenue of DKK42.03B [4/29/2022 7:46 AM]	113.73	3.54 (3.21%)	114.42	4.23 (3.84%)	73.53 - 122.16	3,092,975	1,240,000	49,309
Novo Nordisk GAAP EPS of DKK6.22, revenue of DKK42.03B [4/29/2022 7:46 AM] Novo Nordisk once weekly insulin icodec bests Tresiba in lowering blood sugar [4/28/2022 2:24 PM] Novo Nordisk gains after lifting 2022 outlook [4/29/2022 8:43 AM] Novo Nordisk stock rises on Q1 show, raised FY22 sales outlook, boosted buyback [4/29/2022 9:16 AM] Novo Nordisk A/S Total number of voting rights and share capital in Novo Nordisk A/S as of 29 April 2022 [Apr-29-22 07:08AM] UPDATE 1-Earnings, tech rally lift European stocks at end of choppy April [Apr-29-22 05:14AM] Novo Nordisk lifts 2022 outlook after strong quarter, shares jump [Apr-29-22 03:27AM] Novo Nordisk's sales increased by 24% in Danish kroner and by 18% at constant exchange rates to DKK 42.0 billion in the first three months of 2022 [Apr-29-22 02:47AM] Novo Nordisk's sales increased by 24% in Danish kroner and by 18% at constant exchange rates to DKK 42.0 billion in the first three months of 2022 [Apr-29-22 02:39AM] Once-weekly insulin icodec demonstrates superior reduction in HbA1c vs insulin degludec in people with type 2 diabetes in ONWARDS 2 phase 3a trial [Apr-28-22 10:54AM] Here We Go Again: Stock Market Indexes Fade; Meta Platforms Soars, But GPD Falls In Q1 [Apr-28-22 10:36AM] Here We Go Again: Stock Market Indexes Fade; Meta Platforms Soars, But GDP Falls In Q1 [Apr-28-22 10:36AM] 5 Big Pharma, Biotech Stocks Set to Beat Q1 Earnings Estimates [Apr-29-22 07:43AM] UPDATE 2-Miners, earnings lift European stocks at end of choppy April [Apr-29-22 05:14AM] Novo Nordisk (NVO) Q1 2022 Earnings Call Transcript [Apr-29-22 12:30PM]
03-11-2021	PM		NVO	Novo Nordisk	257,709	0.84	0.80	0.00	Novo Nordisk reports Q3 results; updates full year guidance [11/3/2021 8:57 AM]	115.62	5.57 (5.06%)	111.78	1.73 (1.57%)	65.19 - 115.95	1,875,850	820,000	53,551
Novo Nordisk reports Q3 results; updates full year guidance [11/3/2021 8:57 AM] UPDATE 2-After strong quarter, Novo Nordisk urges more competitive US obesity market [Nov-03-21 03:14AM] After strong quarter, Novo Nordisk urges more competitive US obesity market [Nov-03-21 02:43AM] Novo Nordisk's net profit increased by 12% in the first nine months of 2021 [Nov-03-21 02:30AM] 10 Best Diabetes Stocks To Buy Now [Nov-02-21 07:39AM] Novo Nordisk A/S Share repurchase programme [Nov-02-21 06:02AM] Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio [Nov-03-21 10:00AM] Novo Nordisk's (NVO) Q3 Earnings and Sales Beat Estimates [Nov-03-21 01:21PM] Novo Nordisk A/S (NVO) Q3 2021 Earnings Call Transcript [Nov-03-21 06:30PM]
05-05-2021	PM		NVO	Novo Nordisk A/S	170,450	0.88	0.79	0.75	Novo Nordisk EPS beats by $4.62, beats on revenue [5/5/2021 6:49 AM]	74.07	-0.06 (-0.08%)	74.07	0.0 (0.00%)	61.53 - 75.86	1,365,383	810,000	7,223
Novo Nordisk reports Q1 results [5/5/2021 6:49 AM] Novo Nordisk rise 3% on Q1 results; 2021 outlook raised [5/5/2021 7:24 AM] Novo Nordisk boosts 2021 sales, profit growth outlook [5/5/2021 7:52 AM] Novo Nordisk A/S Share repurchase programme [May-04-21 10:38AM] Novo Nordisk ups guidance after Q1 results beat expectations [May-05-21 02:13AM] Novo Nordisk's net profit increased by 6% in the first three months of 2021 [May-05-21 01:30AM] Novo Nordisk lifts guidance after first quarter beats expectations [May-05-21 02:13AM] Novo Nordisk's (NVO) Q1 Earnings and Sales Beat Estimates [May-05-21 09:15AM] Novo Nordisk A/S to Host Earnings Call [May-05-21 10:45AM] Novo Nordisk A/S (NVO) Q1 2021 Earnings Call Transcript [May-05-21 07:30PM]
03-02-2021	PM		NVO	Novo Nordisk A/S	162,740	0.64	0.59	0.55	Novo Nordisk reports Q4 results [2/3/2021 5:25 AM]	72.49	2.00 (2.14%)	72.90	1.93 (2.72%)	49.24 - 73.92	1,301,402	964,755	41,839
Novo Nordisk EPS beats by DKK0.07, beats on revenue [2/3/2021 5:25 AM] Novo Nordisk tops Q4 forecast; shares up 4% [2/3/2021 5:54 AM] Novo Nordisk's (NVO) Q4 Earnings and Sales Beat Estimates [Feb-03-21 08:56AM] Novo Nordisk: Q4 Earnings Insights [Feb-03-21 08:37AM] Diabetes drugmaker Novo Nordisk upbeat on 2021, sees Biden boost [Feb-03-21 04:24AM] Novo Nordisk's net profit increased by 8% in 2020 [Feb-03-21 01:30AM] Novo Nordisk A/S Share repurchase programme [Feb-02-21 09:19AM]
30-10-2020	PM		NVO	Novo Nordisk As	156,712	0.69	0.68	0.00	Novo Nordisk reports Q3 results [10/30/2020 5:18 AM]	63.83	-2.50 (-3.77%)	64.94	-1.38 (-2.09%)	49.24 - 73.81	1,744,881	1,015,855	139,189

06-08-2020	PM	0:00 AM ET (Aug 6)	NVO	Novo Nordisk A/S	152,470	0.67	0.64	0.61	Novo Nordisk EPS beats by DKK0.15, misses on revenue [8/6/2020 4:29 AM]	63.70	-1.39 (-2.14%)	64.09	-1.00 (-1.54%)	48.44 - 68.96	1,000,787	1,049,205	94,255

06-05-2020	PM		NVO	Novo Nordisk A/S	149,090	0.75	0.73	0.66		63.13	-0.49 (-0.77%)	62.90	-0.23 (-0.36%)	46.47 - 65.88	1,884,620	1,241,341	33,352